In conclusion, we have demonstrated that elevated YKL-40 levels are associated with increased risk of gastrointestinal cancer, independently of CRP levels and that elevated CRP levels are associated with increased risk of lung cancer, independently of YKL-40 levels. The gene discussed is CHI3L1; the disease is lung carcinoma.